We have observed
5 EP applications
Mylène Audrey Séverine Quellari
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after May 28, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
ANTICANCER DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
NOVEL THERAPEUTIC USE OF P75 RECEPTOR ANTAGONISTS
NOVEL INDOLIZINE DERIVATIVES, AND PREPARATION AND THERAPEUTIC USE THEREOF
4-[5-(3-CHLORO-PHENOXY)-OXAZOLO[5,4-D]PYRIMIDIN-2-YL]-2,6-DIMETHYL-PHENOXY}-ACETIC ACID FOR USE IN THE PREVENTION OR TREATMENT OF ACUTE KIDNEY INJURY
CABAZITAXEL AND ITS USE FOR TREATING CANCER